You just read:

JHL Biotech's Clinical Trial Application Accepted by China for Bevacizumab Biosimilar to Treat Colorectal, Lung, and Ovarian Cancers

News provided by

JHL Biotech, Inc.

16 Apr, 2018, 23:22 BST